Shuttle Pharma Q1 FY26 net loss narrows 29% to $2.15 million

Shuttle Pharmaceuticals Holdings,Inc.

Shuttle Pharmaceuticals Holdings,Inc.

SHPH

0.00
  • Shuttle Pharmaceuticals posted a net loss of USD 2.15 million for the quarter ended March 31, 2026, narrowing 29%.
  • Operating loss tightened 25% to USD 2.22 million on total operating expenses of USD 2.22 million.
  • Research and development expense fell 83% to 267,240, while general and administrative costs rose 94% to USD 1.16 million.
  • Cash and cash equivalents totaled USD 1.09 million, down 76%, with operating cash outflow of USD 2.42 million.
  • Company closed a March 9 underwritten public offering, generating USD 3.5 million in gross proceeds and using USD 1.25 million of net proceeds for marketing efforts tied to Molecule.ai.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023859), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.